• Questions About Raises, Shuttle Fees Top Administrators Forum
  A UAMS Update article about Meet Your Administrator”
  

 
• Gruenwald Is New U.S. Citizen
  Michael Gruenwald becomes U.S. citizen
  

 
• Gruenwald Is New U.S. Citizen
  Michael Gruenwald becomes U.S. citizen
  

 
• Doughnut Sale to Help UAMS Psychiatry Youth Program
  A UAMS Update article about a bake sale
  

 
• Call-in Announcements, Forums Will Give Employees More Information
  A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center
  

 
• IT Help Desk 400,000th Call Sweepstakes
  IT Help Desk 400,000th Call Sweepstates
  

 
• The UAMS Help Desk Today - Ten Years Later
  The UAMS Help Desk Today - Ten Years Later
  

 
• Free Tickets for UAMS Nights at Ray Winder Field
  A UAMS Update article about UAMS Night with the Travelers
  

 
• ARIA Training Sessions May 19 - June 27 at UAMS
  A UAMS Update article about May 19 - June 27 training sessions
  

 
• Human Research Forum Is May 21
  A UAMS Update article about human research Q & A
  

 
• Accolades, May 2003
  Accolades to UAMS faculty and staff
  

 
• GCRC Deadline Changed to July 1 for Grant Proposals
  A UAMS Update article about GCRC pilot grants
  

 
• History of the Help Desk
  
  

 
• Watch, Look & Listen: Preview of New UAMS Public Service Campaign
  
  

 
• Forum to Discuss Impact of HIPAA on Research
  Update article about HIPAA and research at UAMS
  

 
• Human Research Q and A Forum June 27
  A UAMS Update article about the human research forum
  

 
• Emailed Version of UAMS Notice of Privacy Practices
  UAMS Notice of Privacy Practices
  

 
• Free UAF Symposium Aug. 14-15 on Evolution of Human Diet
  A UAMS Update article about a diet symposium at UAF
  

 
• Tom Butler is Arkansas Administrator of the Year
  Tom Butler of UAMS Is Arkansas Administrator of the Year
  

 
• Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
  Join the Prostate Cancer Race Walk. Click Here for Registration Form.
  

 
• Join the Prostate Cancer Race Walk. Click Here for Registration Form.*
  Join the Prostate Cancer Race Walk. Click Here for Registration Form.
  

 
• Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
  Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
  

 
• Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
  Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS
  

 
• Join UAMS/ACRC Team in Race for the Cure®!
  Join UAMS/ACRC Team in Race for the Cure!
  

 
• Join UAMS/ACRC Team in Race for the Cure®!
  Join UAMS/ACRC Team in Race for the Cure!
  

 
• UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
  UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
  

 
• UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
  UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test
  

 
• Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
  Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion
  

 
• Kids First in Fort Smith Celebrated Fourth in Style
  Kids First in Fort Smith Celebrated Fourth in Style
  

 
• Class of 1948 Dedicates Endowment to Excellence in Education
  Class of 1948 Dedicates Endowment to Excellence in Education
  

 
• Pharmacy Professor Elected to American College of Clinical Pharmacy
  Pharmacy Professor Elected to American College of Clinical Pharmacy
  

 
• Pharmaceutical Scientists, Graduate Students Meet at UAMS
  Pharmaceutical Scientists, Graduate Students Meet at UAMS
  

 
• Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
  Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy
  

 
• New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
  New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health
  

 
• Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™
  UAMS, KATV Launch Get Healthy Arkansas™
  

 
• UAMS Expands Video Conferences To Improve Cancer Care in South Arkansas
  UAMS Expands Video Conferences To Improve Cancer Care in South Arkansas, LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) is expanding its video conference network in six counties in south Arkansas to link more local physicians with cancer experts here. UAMS has received a grant from the Office for the Advancement of Telehealth in the Health Resources Services Administration, a division of the U.S. Department of Health and Human Services, to expand oncology education and direct patient consultation via interactive video in Bradley, Calhoun, Ouachita, Polk, Hempstead, and Union Counties. The grant of $736,362 is for three years. Local hospitals will contribute another $408,000 to the project. “There are very few oncology specialists in south Arkansas,” said Ann Bailey Bynum, Ed.D., director of the UAMS Rural Hospital Program. “They have only two medical oncologists and one radiation oncologist serving a rural population of almost 200,000. We want to decrease health care provider isolation in those areas. We think this will increase communication and provide a greater integration of services.” Living conditions in the counties covered by the grant are some of Arkansas’ worst. They have a disproportionate number of low-income, elderly, and minority residents and suffer some of the highest cancer death rates in the state. In the two-year period that ended in June 2002, 523 cancer patients were referred to the Arkansas Cancer Research Center (ACRC) at UAMS from the six counties. “These are usually some of the most challenging and difficult cases to treat,” Bynum said. Expansion of the interactive video network will allow highly trained cancer specialists at ACRC to provide public education in a long-distance classroom-like setting. In addition they can consult directly with patients and their local physicians, make diagnoses, and conduct follow-up visits. Thanks to interactive video, patients will be exposed to the kind of multi-disciplinary team approach that is rarely available in their hometown clinics and physician offices. UAMS will expand interactive video programming already available at Bradley County Medical Center in Warren, Mena Medical Center, Ouachita County Medical Center in Camden, and the UAMS South Arkansas Area Health Education Center in El Dorado. It also will install new videoconferencing equipment at the Community Health Center in Hampton, the Migrant Health Center in Hope, the Medical Center of South Arkansas in El Dorado, and the Arkansas Cancer Research Center (ACRC) at UAMS. New interactive video equipment, including telemicroscopes, electronic stethoscopes, and oral exam cameras, is now being installed in the various locations. Transmission equipment will soon be set up at ACRC. The grant will also pay the salary of a full-time coordinator, and partially fund the salaries of nine other employees, including six site coordinators, one in each county. Since 1991, UAMS has been sharing i
  

 
• Two Breast Cancer Activists with UAMS Ties Are National “Yoplait Champions”
  Two Breast Cancer Activists with UAMS Ties Are National “Yoplait Champions”
  

 
• Rep. Gary Biggs to Host Hearing on Public Health Nov. 3
  Rep. Gary Biggs to Host Hearing on Public Health Nov. 3
  

 
• Tobacco Funds Help Arkansas Aging Initiative
  PINE BLUFF – Thanks in part to the state’s tobacco settlement funds, Arkansas’ fifth satellite center for geriatric education and clinical care, the South Central Center on Aging, opened here today. The Arkansas Aging Initiative, a program of the Donald W. Reynolds Center on Aging at the University of Arkansas for Medical Sciences (UAMS), established the center in partnership with Jefferson Regional Medical Center (JRMC) and the UAMS Area Health Education Center (AHEC) Pine Bluff. The initiative is a component of the state’s program to spend tobacco settlement funds on health promotion. The center is in the I-530 Medical Mall on Dusty Lake Drive. Dale Terrell, M.D., a geriatrician, is director of the center, which will provide comprehensive health education, patient care and coordination of services by an interdisciplinary team including a geriatrician, advanced practice nurses, physical and occupational therapists, pharmacists, nutritionists, and social workers. The center provides primary and consultation services, and may provide specialty clinics and rehabilitation services for patients as needed. The center accepts patients who are 65 and older. A referral is not necessary in most cases. Theresa Horton, M.N.Sc, APN, is education director. The center also will train caregivers to care for senior citizens in their homes, will offer community education about aging and associated health problems, and will maintain a resource library for patients and their families. The center’s steering committee includes Tamer Alsebai, M.D., William Nuckolls, M.D., Freeman Montaque, M.D., James Lindsey, M.D., H. Marks Attwood, M.D., Dale Terrell, M.D., Robert Atkinson, Mark Winslow, Julie Bridgforth, Wilbur West, Larnell Davis, Diann Williams, M.S.N., R.N., Betty Bradshaw, J. Maples, Jr., R.N. and Theresa Horton, M.N.Sc., APN, Pine Bluff, and Claudia Beverly, Ph.D., R.N., FAAN, Ronni Chernoff, Ph.D., R.D., Robin McAtee, B.S.N., MHSA and Gwynn Davis, R.N., M.N.Sc. The goal of the tobacco-funded Arkansas Aging Initiative is to ensure that all older Arkansans have appropriate health care within 50 miles of their homes. UAMS received an allocation from the state’s share of the 1998 nationwide tobacco settlement to establish seven satellites of the Donald W. Reynolds Center on Aging, a comprehensive center for patient care, research on aging, and advanced training of physicians and other health care professionals who specialize in geriatrics, the medical specialty devoted to elderly patients. In each community, the initiative has collaborated with one or more local health care agencies to create the satellite. Working with local partners, UAMS has established centers in Springdale, El Dorado, Jonesboro and Texarkana and plans centers in Fort Smith and West Memphis.
  

 
• UAMS Receives $665,000 to Study Depression and Drug Abuse
  UAMS has received a five-year grant of $665,000 from the National Institute on Drug Abuse to study best practices for treating depression in substance abusers.
  

 
• UAMS Breast Cancer Expert Receives Hickingbotham Award
  from Susan G. Komen Breast Cancer Foundation
  V. Suzanne Klimberg, M.D., director of the Breast Cancer Program in the Arkansas Cancer Research Center (ACRC) at UAMS, recently received the Hickingbotham Award for Service from the Arkansas affiliate of the Susan G. Komen Breast Cancer Foundation. “You reach beyond professional interests to the interest and needs of the Komen Foundation and the cause of breast cancer,” President Barbara Daugherty of the affiliate told Klimberg in notifying her of the award. The Komen Foundation has been a generous supporter of the Breast Cancer Program at UAMS, contributing more than $500,000 to the program in recent years. It earlier awarded Klimberg a two-year fellowship to train surgeons in the comprehensive and special needs of breast cancer patients. Employees of UAMS had the largest team in the October 4 Race for the Cure™ in Little Rock. The race is an annual fundraiser for the Komen Foundation.
  

 
• UAMS Adds Degree in Medical Dosimetry, One of First in Nation
  LITTLE ROCK – The University of Arkansas for Medical Sciences (UAMS) is starting one of the nation’s first degree programs in medical dosimetry and will offer bachelor degrees and advanced certificates. Medical dosimetrists work as part of radiation therapy teams in hospitals and radiation therapy centers, calculating the proper doses of radiation for individual patients. Dosimetrists use computer programs and three-dimensional images to calculate the doses. The Arkansas Higher Education Coordinating Board recently gave final approval to UAMS to offer the degree. The other dosimetry programs are in Texas, California, Massachusets, Georgia, and North Carolina. Nikos Papanikolaou, Ph.D., will direct the medical dosimetry program, which will be part of the Department of Radiation Therapy in the UAMS College of Health Related Professions. Debra Tomlinson chairs the department, jointly supported by CARTI (Central Arkansas Radiation Therapy Institute). The program will accept its first class in the fall of 2004. For more information about the degree/certificate program, call the Department of Radiation Therapy at (501) 660-7623.
  

 
• Minimally Invasive Hip Replacements Are Just the Latest
  Innovation in Orthopaedic Surgery at UAMS
  Minimally Invasive Hip Replacements Are Just the Latest Innovation in Orthopaedic Surgery at UAMS
  

 
• UAMS Cancer Researcher Formally Named
  Josetta Edwards Wilkins Chair in Breast Cancer Research
  UAMS Cancer Researcher Formally Named Josetta Edwards Wilkins Chair in Breast Cancer Research Josetta Edwards Wilkins Chair in Breast Cancer Research, LITTLE ROCK – Thomas Kieber-Emmons, Ph.D., a prominent researcher on potential vaccines for preventing recurrences of cancer, was formally installed as the first Josetta Edwards Wilkins, E.D., Chair in Breast Cancer Research at the University of Arkansas for Medical Sciences (UAMS) today. Kieber-Emmons is a professor of pathology in the UAMS College of Medicine and director of breast cancer research development at the Arkansas Cancer Research Center (ACRC) at UAMS. UAMS established the academic position to honor former state representative Josetta Edwards Wilkins of Pine Bluff, who was the lead sponsor of legislation in 1997 to allocate $4 million to UAMS for breast cancer research. UAMS placed $1 million in an endowment that will generate annual income for research. As the first chairholder, Kieber-Emmons will receive the endowment income to fund his research. University of Arkansas System President B. Alan Sugg, Ph.D.; state Sen. Henry Wilkins IV; and state Rep. Jay Bradford spoke at the installation ceremony, called an investiture, in Sam M. Walton Auditorium at the ACRC. Sugg presented a medallion representing the academic chair as a memento to Dr. Wilkins. Chancellor I. Dodd Wilson, M.D., presided over the ceremony and, with Dean E. Albert Reece, M.D., Ph.D., M.B.A., presented a second medallion to Kieber-Emmons. Ralph D. Sanderson, Ph.D., director of basic research at the ACRC and also a professor of pathology in the College of Medicine, and Heinz Kohler, M.D., Ph.D., of the University of Kentucky, spoke at the ceremony. Afterward, James Y. Suen, M.D., director of the ACRC, welcomed guests to a reception for Kieber-Emmons.
  

 
• Jonesboro Resident Spends Summer
  as Partner in Research at UAMS
  Jonesboro Resident Spends Summer as Partner in Research at UAMS as Partner in Research at UAMS, Adam Woodruff, a Jonesboro resident and second-year student in the College of Medicine at the University of Arkansas for Medical Sciences (UAMS), spent the summer learning about cancer research, patient care and education. He was one of 28 medical, pharmacy and undergraduate students who participated in the 10-week Partners in Research (PIR) Program offered by the Arkansas Cancer Research Center (ACRC) at UAMS. Woodruff and the other students attended weekly lectures by ACRC faculty and shadowed clinicians to learn firsthand how physicians interact with patients. They also worked in labs alongside basic scientists to conduct research in ongoing ACRC studies. At the end of the program, the students presented their research findings at a scientific symposium. This was the 28th year that UAMS offered PIR, which is sponsored by the National Cancer Institute.
  

 
• Osceola Native Receives White Lab Coat at
  Special Ceremony for First-Year UAMS Medical Students
  Osceola Native Receives White Lab Coat at Special Ceremony for First-Year UAMS Medical Students
  

 
• Breakthrough Discovery Puts UAMS Closer to Cure
  for Multiple Myeloma
  Breakthrough Discovery Puts UAMS Closer to Cure for Multiple Myeloma
  

 
• Preventing Premature Birth Will Be Focus of UAMS Conference Feb. 19-20
  Preventing Premature Birth Will Be Focus of UAMS Conference Feb. 19-20
  

 
• Depression in Pregnancy Topic of Lectures at UAMS Jan. 14, 15
  Depression in Pregnancy Topic of Lectures at UAMS Jan. 14, 15
  

 
• UAMS History of Medicine Award Available
  UAMS History of Medicine Award Available
  

 
• UAMS History of Medicine Award Available
  UAMS History of Medicine Award Available
  

 
• Doctor Who Treated JFK at Dallas to Speak at UAMS March 31
  Doctor Who Treated JFK at Dallas to Speak at UAMS March 31
  

 
• Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
  Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
  

 
• Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
  Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
  

 
• Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09)
  Novel biomarker profile for the management of metastisis to bone of patients with breast cancer.
  

 
• Gray’s Anomaly: A Source of Empowerment
  Feb. 8, 2012 | “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed.
  

 
• Need Something Sweet for Your Valentine?
  Need Something Sweet for Your Valentine?
  

 
• Need Something Sweet for Your Valentine?
  Need Something Sweet for Your Valentine?
  

 
• Code Moo Now Open
  Code Moo Now Open
  

 
• Code Moo Now Open
  Code Moo Now Open
  

 
• Sign Up for the UAMS House of Delegates Relay for Life Team
  UAMS House of Delegates Relay for Life Team
  

 
• Sign Up for the UAMS House of Delegates Relay for Life Team
  UAMS House of Delegates Relay for Life Team
  

 
• Overwhelming Response to SmartCare
  Overwhelming Response to SmartCare
  

 
• Overwhelming Response to SmartCare
  Overwhelming Response to SmartCare
  

 
• Celebrating African American Women Firsts
  Celebrating African American Women Firsts
  

 
• Celebrating African American Women Firsts
  Celebrating African American Women Firsts
  

 
• Nutrition Department Hosts Food Drive
  Nutrition Department Hosts Food Drive
  

 
• Nutrition Department Hosts Food Drive
  Nutrition Department Hosts Food Drive
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
  Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
  Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11
  Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 
• In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11)
  Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
  

 

Lowe, M.D., Diane Mackey, Jack Reynolds, John A. Riggs IV, and Nancy Wood, all of Little Rock.